SKVI: Skinvisible, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 2.66
Enterprise Value ($M) 9.18
Book Value ($M) -9.25
Book Value / Share -1.74
Price / Book -0.29
NCAV ($M) -9.36
NCAV / Share -1.76
Price / NCAV -0.28

Profitability (mra)
Return on Invested Capital (ROIC) n/a
Return on Assets (ROA) -3.69
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 0.01
Current Ratio 0.01

Balance Sheet (mrq) ($M)
Current Assets 0.04
Assets 0.16
Liabilities 9.40
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.02
Operating Income -0.59
Net Income -0.57

Cash Flow Statement (mra) ($M)
Cash From Operations -0.07
Cash from Investing -0.01
Cash from Financing 0.09

(click for more detail)
Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-04-14 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K
2024-11-19 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q
2024-08-15 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q
2024-05-15 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q

(click for more detail)

Similar Companies
SGBI – Sangui Biotech International, Inc. SGFEF – Siegfried Holding AG
SIGO – Sunset Island Group, Inc. SLNCF – Silence Therapeutics plc
SMFL – Smart for Life, Inc.


Financial data and stock pages provided by
Fintel.io